Effect of systolic blood pressure status on coronary inflammation and high-risk plaque characteristics

Table 6 Univariate and multivariate linear analysis on pericoronary adipose tissue attenuation of left anterior descending artery in type 2 diabetes mellitus patients with hypertension

	Univariate		Multivariate
	β (95%CI)	P value	β (95%CI)	P value
Subgroup
Low SBPV group	Reference
High SBPV group	1.055 (0.510-2.527)	0.029	1.673 (0.016-3.330)	0.048
Subgroup
Controlled SBP group	Reference
Uncontrolled SBP group	2.064 (0.577-3.552)	0.017	2.370 (0.755-3.984)	0.004
Age	0.007 (-0.056-0.071)	0.824
Male sex	2.288 (0.933-3.643)	0.001	2.237 (0.824-3.651)	0.962
Body mass index	-0.306 (-0.505 to -0.106)	0.003	-0.317 (-0.513 to -0.120)	0.002
Smoking	0.319 (-1.422-2.061)	0.719
Dyslipidemia	-0.996 (-2.382-0.391)	0.159
Fast glucose	-0.047 (-0.261-0.166)	0.663
HbA1c	0.283 (-0.140-0.705)	0.189
Triglyceride	-0.414 (-0.748 to -0.080)	0.015	-0.445 (-0.817 to -0.072)	0.019
Total cholesterol	-0.135 (-0.704-0.435)	0.643
HDL-cholesterol	1.110 (-0.759-2.979)	0.244
LDL-cholesterol	-0.108 (-0.829-0.613)	0.770
Statin	-0.798 (-2.297-0.700)	0.296
Hypertension treatment	0.829 (-0.534-2.192)	0.233
Diabetes treatment	-0.578 (-2.010-0.854)	0.428

SBPV: Systolic blood pressure variability; SBP: Systolic blood pressure; LDL: Low-density lipoprotein; HDL: High-density lipoprotein; HbA1c: Glycated hemoglobin; 95%CI: 95% confidence interval.